You are here

Eloxx Pharmaceuticals to Present at the Barclays Global Healthcare Conference on March 14, 2019

WALTHAM, Mass., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic fibrosis, cystinosis, inherited retinal disorders, and other diseases caused by nonsense mutations limiting production of functional proteins, today announced that Robert E. Ward, Chairman and Chief Executive Officer of Eloxx, will make a company presentation and host one-on-one meetings with investors at the Barclays Global Healthcare Conference on Thursday, March 14, 2019, at the Loews Miami Beach Hotel.
Wednesday, February 20, 2019 - 16:00